Barclays Sticks with Buy Rating on UnitedHealth

Barclays analyst Andrew Mok CFA has maintained his buy rating for UnitedHealth (UNH.US), keeping its target price at $441. According to TipRanks data, Mok's past performance is marked by a success rate of 51.1% and an average total return of -3.5% over the past year.

Mok's track record shows that his ratings have been successful in generating positive returns for investors. However, it's essential to note that past performance does not guarantee future results.